Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Non-Current Liabilities (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 188.55% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 188.55% year-over-year, with the annual reading at $5.6 million for FY2025, 188.55% up from the prior year.
  • Other Non-Current Liabilities hit $5.6 million in Q4 2025 for Harmony Biosciences Holdings, up from $1.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $5.6 million in Q4 2025 to a low of $831000.0 in Q1 2021.
  • Historically, Other Non-Current Liabilities has averaged $2.1 million across 5 years, with a median of $1.9 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 270.4% in 2022 and later plummeted 49.52% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $3.2 million in 2021, then decreased by 21.28% to $2.5 million in 2022, then decreased by 15.67% to $2.1 million in 2023, then decreased by 7.68% to $1.9 million in 2024, then skyrocketed by 188.55% to $5.6 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for HRMY at $5.6 million in Q4 2025, $1.2 million in Q3 2025, and $1.4 million in Q2 2025.